A Clinical Trial to Evaluate the Safety and Efficacy ofApixaban In Subjects with a Recent Acute Coronary Syndrome
Phase 3
- Registration Number
- CTRI/2009/091/000249
- Lead Sponsor
- BristolMyers Squibb
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 1080
Inclusion Criteria
Ages Eligible for Study: 18 Years and older
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria:
Acute coronary syndrome (ACS)
Clinically stable
Receiving standard of care for ACS
Exclusion Criteria
Exclusion Criteria:
Severe hypertension
Active bleeding or high risk for major bleeding
Hemoglobin less than 9 g/dL
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method